CK Life Sciences Int'l., (Holdings) Inc. reported near-unanimous approval of every agenda item at its Annual General Meeting on 21 May 2026.

• Adoption of the 2025 audited financial statements received 7.27 billion votes in favour and 0.10 million against, translating to 99.9986% support.

• All five directors standing for re-election secured mandates. The narrowest margin was for Independent Non-executive Director Donald Jeffrey Roberts, who obtained 7.23 billion votes (99.48% support).

• Deloitte Touche Tohmatsu was re-appointed as auditor with 7.24 billion votes (99.57% support); 0.03 billion votes were cast against.

• Shareholders approved directors’ fees and committee fees, each drawing 99.9994% support.

• General mandates authorising the board to issue additional shares and to repurchase shares passed with 99.9992% and 99.9970% approval, respectively.

The meeting covered 9.61 billion ordinary shares eligible to vote, and all company directors were in attendance. Computershare Hong Kong Investor Services acted as poll scrutineer.